Cost effectiveness of memantine in the treatment of moderately severe and severe Alzheimer's disease in Spain

被引：4
|
作者：
Antonanzas, F
Badenas, J
François, C
Guilhaume, C
机构：
[1] Univ La Rioja, Logrono, Spain
[2] H Lundbeck & Co AS, Barcelona, Spain
[3] H Lundbeck & Co AS, Paris, France
来源：
VALUE IN HEALTH | 2003年 / 6卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)61949-3
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：765 / 765
页数：1
相关论文
共 50 条
  • [31] Memantine (Namenda) for moderate to severe Alzheimer's disease
    Ables, AZ
    [J]. AMERICAN FAMILY PHYSICIAN, 2004, 69 (06) : 1491 - 1492
  • [32] Memantine in moderate-to-severe Alzheimer's disease
    Bleich, S
    Wiltfang, J
    Kornhuber, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (06): : 609 - 610
  • [33] Spotlight on Memantine in Moderate to Severe Alzheimer's Disease
    McKeage, Kate
    [J]. DRUGS & AGING, 2010, 27 (02) : 177 - 179
  • [34] Modelling the cost effectiveness of cholinesterase inhibitors in the management of mild to moderately severe Alzheimer's disease - The authors' reply
    Green, C
    Picot, J
    Loveman, E
    Takeda, A
    Kirby, J
    Clegg, A
    [J]. PHARMACOECONOMICS, 2006, 24 (06) : 625 - 626
  • [35] Resource Utilisation and Cost Analysis of Memantine in Patients with Moderate to Severe Alzheimer’s Disease
    Anders Wimo
    Bengt Winblad
    Albrecht Stöffler
    Yvonne Wirth
    Hans-Jörg Möbius
    [J]. PharmacoEconomics, 2003, 21 : 327 - 340
  • [36] Resource utilisation and cost analysis of memantine in patients with moderate to severe Alzheimer's disease
    Wimo, A
    Winblad, B
    Stoffler, A
    Wirth, Y
    Möbius, HJ
    [J]. PHARMACOECONOMICS, 2003, 21 (05) : 327 - 340
  • [37] Added Therapeutic Value of Memantine in the Treatment of Moderate to Severe Alzheimer’s Disease
    T. Heinen-Kammerer
    H. Rulhoff
    S. Nelles
    R. Rychlik
    [J]. Clinical Drug Investigation, 2006, 26 : 303 - 314
  • [38] Memantine treatment for mild to severe Alzheimer's disease:: Clinical trials summary
    Tariot, PN
    Doody, R
    Peskind, ER
    Winblad, B
    Stöffler, A
    Graham, SM
    Jonas, JM
    McDonald, S
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S381 - S381
  • [39] Added therapeutic value of memantine in the treatment of moderate to severe Alzheimer's disease
    Heinen-Kammerer, T.
    Rulhoff, H.
    Nelles, S.
    Rychlik, R.
    [J]. CLINICAL DRUG INVESTIGATION, 2006, 26 (06) : 303 - 314
  • [40] Memantine treatment for mild to severe Alzheimer's disease:: Clinical trials summary
    Tariot, PN
    Doody, R
    Peskind, E
    Winblad, B
    Stöffler, A
    Graham, SM
    McDonald, S
    [J]. NEUROBIOLOGY OF AGING, 2004, 25 : S99 - S100
12345